Why the study?
Does ablation targeting fibrotic areas (scar homogenization) improve outcomes in patients with atrial fibrillation undergoing ablation?
Does ablation targeting fibrotic areas (scar homogenization) improve outcomes in patients with atrial fibrillation undergoing ablation?
Scar homogenization is a promising additional substrate modification strategy in AF ablation, but requires standardized methodology and validation in large-scale clinical trials.
Scar homogenization may enhance AF ablation outcomes; leaves open standardized protocols and large RCT validation.
Laboratory studies, histology studies, image studies and the clinical studies all prove the positive correlation between atrial fibrillation and atrial fibrosis from different perspectives. Atrial fibrosis, by separating myocardial cell coupling, diminishing conduction velocity and promoting anisotropic conduction, produce the substrate to sustain atrial fibrillation (AF). These fibrotic areas can be translated into signal abnormalities (low voltage and complex electrgram), and be depicted by electroanatomic high density map. Ablation targeting these areas after circumferential pulmonary vein produces isolation as the additional substrate modification strategy has proved its beneficial results. However, the unified methodology regarding the scar definition, the mapping rhythm (AF or sinus rhythm) and the modification endpoint is yet to be negotiated. Large-scale clinical trials, long-term follow-up results are needed to prove its contribution to the overall success rate of AF ablation.
No takes yet. Share an insight, caveat, or question.
Minglong Chen (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: